Skip to content
Screener

Chemours CC Noncontrolling interests in subsidiaries

Noncontrolling interests in subsidiaries at other companies

VHI
ValhiVHI
$355.1M-0.9%
NL Industries logo
NL IndustriesNL
$18.81M-3.2%
Tronox logo
TronoxTROX
$30M-9.1%
Eastman Chemical logo
Eastman ChemicalEMN
$77M+5.5%
Cabot Corporation logo
Cabot CorporationCBT
$119M-27.0%
Innospec logo
InnospecIOSP
$7.2M+26.3%

Other financials

Income statement

See full
Revenue$1.6B-1.5%
Gross profit$286.0M+2.9%
Net income-$274.0M+27.9%
EPS (diluted)-$1.81+28.5%

Balance sheet

See full
Cash & equivalents$671.0M+33.7%
Total debt$4.2B-6.5%
Total equity-$49.0M-121%
Total assets$7.2B-4.2%

Cash flow

See full
Operating cash flow$158.0M+69.9%
CapEx$44.0M+2.3%
Free cash flow$114.0M—

Valuation

See full
Market cap$2.37B+29.9%
Enterprise value$5.86B+1.5%
P/S0.4×+0.1×

Profitability

See full
Gross margin15.3%-2.9pp
Net margin-5.2%-1.2pp
FCF margin5.1%-1.7pp

Returns & leverage

See full
Return on equity-105%-107pp
Debt / equity20.6×+12.8×
Current ratio1.7×0.0×

Where this comes from

Reported directly by Chemours in its filing.

Tagged under the XBRL concept us-gaap:MinorityInterest.

The source filing: Chemours’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 11:06 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001627223-26-000024
Line itemJune 30, 2026December 31, 2025
Treasury stock, at cost (48,813,294 shares at June 30, 2026 and 48,826,793 at December 31, 2025)(1,801)(1,802)
Additional paid-in capital1,0881,074
Retained earnings8911,220
Accumulated other comprehensive loss(229)(244)
Total Chemours stockholders’ equity(49)250
Non-controlling interests11
Total equity(48)251
Total liabilities and equity$7,150$7,382

Item 1. INTERIM CONSOLIDATED FINANCIAL STATEMENTS

FAQ

What is Chemours's noncontrolling interests in subsidiaries?
Chemours (CC) reported noncontrolling interests in subsidiaries of $1M in Q2 2026.
How has Chemours's noncontrolling interests in subsidiaries changed year-over-year?
Chemours's noncontrolling interests in subsidiaries decreased by 50.0% year-over-year, from $2M to $1M.
What is the long-term trend for Chemours's noncontrolling interests in subsidiaries?
Over 4 years (2020 to 2025), Chemours's noncontrolling interests in subsidiaries has grown at a -15.9% compound annual growth rate (CAGR), from $2M to $1M.
What does noncontrolling interests in subsidiaries mean?
This represents the portion of a subsidiary's net assets that is owned by outside shareholders rather than the parent company. It is reported within equity to show the total value of the subsidiary's assets and liabilities that are not attributable to the parent. It reflects the non-controlling stake in consolidated entities.

Ask your AI about Chemours's noncontrolling interests in subsidiaries.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude